Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue        
Total revenue
Operating expenses:        
Research and development, net of reimbursements 8,825 11,081 15,460 18,930
General and administrative 3,593 4,561 6,555 8,296
Total operating expenses 12,418 15,642 22,015 27,226
Loss from operations (12,418) (15,642) (22,015) (27,226)
Other income:        
Interest income - net 1,065 461 1,992 1,008
Total other income 1,065 461 1,992 1,008
Net loss $ (11,353) $ (15,181) $ (20,023) $ (26,218)
Net loss per common share – basic (in Dollars per share) $ (0.38) $ (0.58) $ (0.69) $ (1.01)
Weighted average common shares outstanding – basic (in Shares) 30,103,063 26,217,910 28,994,775 25,958,706
Revenue        
Revenue        
Total revenue
Other Revenue        
Revenue        
Total revenue